tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SNDX Stock Latest News

Incyte, Syndax announce FDA approval for Niktimvo vial sizes
The FlyIncyte, Syndax announce FDA approval for Niktimvo vial sizes
3d ago
INCY
SNDX
Syndax price target lowered to $16 from $18 at Scotiabank
PremiumThe Fly
Syndax price target lowered to $16 from $18 at Scotiabank
10d ago
SNDX
Syndax Pharmaceuticals Restructures Leadership Team
PremiumCompany Announcements
Syndax Pharmaceuticals Restructures Leadership Team
29d ago
8K
SNDX
Syndax announces additional positive data from AUGMENT-101 trial of Revuforj
PremiumThe Fly
Syndax announces additional positive data from AUGMENT-101 trial of Revuforj
1M ago
SNDX
Kura Oncology price target lowered to $18 from $22 at Scotiabank
PremiumThe Fly
Kura Oncology price target lowered to $18 from $22 at Scotiabank
2M ago
KURA
SNDX
Syndax price target raised to $38 from $33 at JPMorgan
PremiumThe FlySyndax price target raised to $38 from $33 at JPMorgan
2M ago
SNDX
Syndax price target raised to $45 from $37 at Citi
Premium
The Fly
Syndax price target raised to $45 from $37 at Citi
2M ago
SNDX
Syndax price target raised to $43 from $35 at BTIG
Premium
The Fly
Syndax price target raised to $43 from $35 at BTIG
2M ago
SNDX
Syndax price target raised to $51 from $49 at H.C. Wainwright
PremiumThe Fly
Syndax price target raised to $51 from $49 at H.C. Wainwright
2M ago
SNDX
Syndax confirms FDA approval of Revuforj for acute leukemia
PremiumThe Fly
Syndax confirms FDA approval of Revuforj for acute leukemia
2M ago
SNDX
FDA approves Syndax’s Revuforj for acute leukemia
PremiumThe Fly
FDA approves Syndax’s Revuforj for acute leukemia
2M ago
SNDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RNA
AGEN
Charter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz
PremiumThe FlyCharter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz
2M ago
MA
RH
Syndax price target lowered to $18 from $23 at Scotiabank
Premium
The Fly
Syndax price target lowered to $18 from $23 at Scotiabank
2M ago
SNDX
Leerink views Syndax data as potentially positive for Kura Oncology’s ziftomenib
Premium
The Fly
Leerink views Syndax data as potentially positive for Kura Oncology’s ziftomenib
2M ago
KURA
SNDX
Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
PremiumThe Fly
Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
2M ago
S
HD
Syndax’s revumenib meets primary results in AML trial
PremiumThe Fly
Syndax’s revumenib meets primary results in AML trial
2M ago
SNDX
Syndax price target raised to $47 from $45 at H.C. Wainwright
PremiumThe Fly
Syndax price target raised to $47 from $45 at H.C. Wainwright
2M ago
SNDX
Syndax Pharmaceuticals: Key Pipeline Developments and Financial Update
PremiumCompany Announcements
Syndax Pharmaceuticals: Key Pipeline Developments and Financial Update
2M ago
SNDX
Syndax reports Q3 EPS (98c), consensus ($1.11)
PremiumThe FlySyndax reports Q3 EPS (98c), consensus ($1.11)
2M ago
SNDX
Syndax narrows FY24 CapEx view to $245M-$250M from $240M-$260M
Premium
The Fly
Syndax narrows FY24 CapEx view to $245M-$250M from $240M-$260M
2M ago
SNDX
Syndax to present new data on revumenib in leukemia
Premium
The Fly
Syndax to present new data on revumenib in leukemia
2M ago
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >